Back Stocks profile

Stock analysis tool for investors

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE:524348

₹545.25 17.45 (3.31%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

530.50

Today’s High

557.00

52W low

431.00

52W High

645.80

Open Price

544.40

Prev. Close

492.0500

Volume

949737.00

Value

517844099.25

Fundamentals

Market Cap Cr

5012.80

Price to Earnings

29.20

Price to Book Value

3.90

Dividend Yield

0.20

PE to Growth

9.50

Op Revenue TTM Cr

2528.58

Net Profit TTM Cr

171.42

Cash From Operating Activity Cr

358.92

Return on Equity %

13.38

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 Jul, 2024

35

Week

38.9

Month

45.7

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

544.23

PIVOT

First Resistance

557.97

Second Resistance

570.68

Third Resistance

584.42

First Support

531.52

Second Support

517.78

Third Support

505.07

Relative Strength Index

69.31

Money Flow Index

70.06

MACD

8.41

MACD Signal

7.06

Average True Range

16.62

Average Directional Index

16.26

Rate of Change (21)

14.33

Rate of Change (125)

11.46

Commodity Channel Index

197.4

Williams %R

-21.1

BETA

1 Month

0.55

3 Month

0.61

1 Year

0.62

3 Year

0.41

PRICE CHANGE ANALYSIS

5.49%

1 Week

Low

High

501.4

556.95

14.33%

1 Month

Low

High

451.05

556.95

16.46%

3 Months

Low

High

451.05

556.95

8.8%

6 Months

Low

High

431.05

568

17.23%

1 Year

Low

High

431.05

645.75

Bigul
02 Jul 2024

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of issue of letter of confirmation in lieu of duplicate share certificate
Bigul
26 Jun 2024

AARTI DRUGS LTD. - 524348 - Closure of Trading Window

Closure of Trading Window
Bigul
25 Jun 2024

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of issue of letter of confirmation in lieu of Duplicate share certificate
Bigul
15 Jun 2024

AARTI DRUGS LTD. - 524348 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

We are enclosing herewith the Scrutinizer''s Report and voting results of postal ballot
Bigul
12 Jun 2024

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of issue of letter of confirmation in lieu of Duplicate Share Certificate
Bigul
30 May 2024

AARTI DRUGS LTD. - 524348 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajendra Vallabhaji Gogri & Others
Bigul
23 May 2024

AARTI DRUGS LTD. - 524348 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the financial year ended March 31, 2024
See all News

FAQs

The latest market price of Aarti Drugs Ltd. on NSE was Rs. 545.25 as of today.

The opening share price of Aarti Drugs Ltd. was Rs. 544.40 as of today.

The 52-week high share price of Aarti Drugs Ltd. was Rs. 645.80.

The 52 week low share price of Aarti Drugs Ltd. was Rs. 431.00.

Aarti Drugs Ltd. has a market cap of Rs. 5012.80 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Aarti Drugs Ltd. is 9.50. Please refer to the Fundamentals section for further details.

The operating revenue for Aarti Drugs Ltd. in the last FY was Rs.  2528.58 crore. Please refer to the Financials section for further details.

The Net Profit for Aarti Drugs Ltd. in the last FY was Rs. 171.42 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Aarti Drugs Ltd. was on 2024-02-06 for Rs. 1 per share. According to today’s share price, the dividend yield of Aarti Drugs Ltd. stands at 0.20. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Aarti Drugs Ltd. was as of 2020-09-30. The bonus ratio declared in this issue was 3:1. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Aarti Drugs Ltd..

Close

Let's Open Free Demat Account